In Parkinson’s disease, autophagy activation via agents such as metformin has shown neuroprotective effects by activating the AMPK/ULK1/PINK1/Parkin pathway, thereby enhancing autophagy and mitophagy, promoting mitochondrial clearance, and reducing neuronal apoptosis in experimental models [112,151]. Here, ULK1 is linked to Parkinson disease.